We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

LifeZig Personalized Reminiscence Video With Slideshows and Music for Individuals With Alzheimer's and Dementia (Lifezig)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00759863
First Posted: September 25, 2008
Last Update Posted: March 2, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Photozig, Inc.
  Purpose

The LifeZig Project is a research study of a new reminiscence activity for individuals with Alzheimer's Disease (AD) and other types of dementia, based on the LifeZig system, with personalized video channels containing old photographs and music on television.

The goal of the LifeZig study is to enhance the quality of life for dementia patients and their families/caregivers, decrease the burden of care, and contribute to positive interaction between dementia patients and families/caregivers.


Condition Intervention Phase
Alzheimer's Disease Dementia Behavioral: Lifezig Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: LifeZig System for Individuals With Alzheimer's Disease

Resource links provided by NLM:


Further study details as provided by Photozig, Inc.:

Primary Outcome Measures:
  • Multidimensional Observation Scale for Elderly Subject [ Time Frame: 6 months ]
    This scale reflects the overall well-being of dementia patients. The construct being assessed is the quality of life of dementia patients, related to patient functioning, disoriented behavior, depression/anxiety, irritable behavior, and withdrawn behavior, consisting of 32 items, divided in four sub-scales: "Personal Care", "Communication, Awareness & Memory", "Mood", and "Interpersonal Awareness Behaviors". The overall score provides an indication of the overall perceived well-being of the dementia patient. Best value = 32. Worst Value = 144.


Secondary Outcome Measures:
  • Revised Memory and Behavior Problems Checklist [ Time Frame: 6 months ]
    This scale measures the type/number of dementia patients disturbing behaviors, and how much they bother caregivers with 24 items describing possible troublesome behaviors that the patient might evidence in the past month. Caregivers are first asked whether the dementia patient had displayed any of these in the time period, and secondly to rate on a 5-point scale (0=not at all; 4= extremely) how much this "bothered or upset" them. A "conditional bother" score is calculated which is the "upset" or "bother" ratings for only the problematic behavior that occurred. Best value = 0. Worst Value = 96.

  • Center for Epidemiologic Studies Depression Scale [ Time Frame: 6 months ]
    The Center for Epidemiological Studies Depression scale (CES-D) is a 20-item measure that asks about the frequency of depressive symptoms (affective, psychological, and somatic) within the past week. The construct being assessed is the caregiver depression. Best value = 0. Worst Value = 60.


Enrollment: 242
Study Start Date: August 2006
Study Completion Date: April 2009
Primary Completion Date: April 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Lifezig
Subjects watch personalized reminiscence video channels developed by program staff with the help of family members/caregivers (using the LifeZig system)
Behavioral: Lifezig
Personalized Reminiscence Video
Other Name: LifeZig Personalized Reminiscence Slideshow
No Intervention: Usual Care
Subjects follow routine activities applied by nurses or caregivers, such as traditional reminiscence, crafts, singing, recreational activities, and other activities.

Detailed Description:
This program creates personalized TV channels with old photographs of AD patients, music, narration and relaxing sounds; as an activity to relax dementia patients.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   21 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Inclusion criteria for dementia patients:

    • documented diagnosis of probable Alzheimer's or other type of dementia, medically stable, and visual/hearing capabilities to watch television.
  • Inclusion criteria for family members/caregivers:

    • provide care or be a family member of dementia patient, have knowledge of the person, and be able to provide old photographs of dementia patient.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00759863


Locations
United States, California
Photozig, Inc.
Moffett Field, California, United States, 94035-0128
Sponsors and Collaborators
Photozig, Inc.
Investigators
Principal Investigator: Bruno Kajiyama, MS Photozig, Inc.
  More Information

Responsible Party: Bruno Kajiyama, Photozig, Inc.
ClinicalTrials.gov Identifier: NCT00759863     History of Changes
Other Study ID Numbers: Pz-A102b
R44AG022261 ( U.S. NIH Grant/Contract )
First Submitted: September 23, 2008
First Posted: September 25, 2008
Results First Submitted: June 22, 2009
Results First Posted: February 23, 2010
Last Update Posted: March 2, 2010
Last Verified: February 2010

Additional relevant MeSH terms:
Alzheimer Disease
Dementia
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Tauopathies
Neurodegenerative Diseases
Neurocognitive Disorders
Mental Disorders